Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Financing Thoughts

<< Previous

Bullboard Posts

Next >>

Comment by Ridgebackon Dec 08, 2010 1:28pm

213 Views

Post# 17819106

RE: Financing Thoughts

The same thing happened with Aquila Resources another Hudbay beneficiary for funding. A very low cost placement. That did not stop AQA for appreciating in values from around 38 cents to over $1.00.

I don't doubt Hudbay will bring this to fruition and to have a Canadian partner with deep pockets is going to help immensely as the projects progress. In the mean time HLO has other projects that need dollars.

Regards

<< Previous

Bullboard Posts

Next >>

2024, a breakthrough year for silver